Macrophage inflammatory protein 3α deficiency in atopic dermatitis skin and role in innate immune response to vaccinia virus
- 28 February 2007
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 119 (2) , 457-463
- https://doi.org/10.1016/j.jaci.2006.10.005
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus ReportJournal of Allergy and Clinical Immunology, 2006
- Cytokines and chemokines orchestrate atopic skin inflammationJournal of Allergy and Clinical Immunology, 2006
- Innate immune defects in atopic dermatitisJournal of Allergy and Clinical Immunology, 2006
- The cornified envelope: a model of cell death in the skinNature Reviews Molecular Cell Biology, 2005
- Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasisJournal of Allergy and Clinical Immunology, 2003
- Many chemokines including CCL20/MIP-3α display antimicrobial activityJournal of Leukocyte Biology, 2003
- Production of Macrophage Inflammatory Protein 3α (MIP-3α) (CCL20) and MIP-3β (CCL19) by Human Peripheral Blood Neutrophils in Response to Microbial PathogensInfection and Immunity, 2003
- The Structure of Human Macrophage Inflammatory Protein-3α/CCL20Journal of Biological Chemistry, 2002
- Human β-Defensin-2 Production in Keratinocytes is Regulated by Interleukin-1, Bacteria, and the State of DifferentiationJournal of Investigative Dermatology, 2002
- Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3α/CCL20 by epidermal keratinocytes and its role in atopic dermatitisInternational Immunology, 2001